Ferring and Astellas enter a license agreement on Degarelix for the treatment of prostate cancer in Japan
Ferring Pharmaceuticals (“Ferring”; headquarters: Lausanne, Switzerland; executive chairman: Frederik Paulsen) and Astellas Pharma Inc….
- 1
- 2